Newsroom

Sorted by: Latest

-

TCPC FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds BlackRock TCP (TCPC) Investors of Securities Class Action Deadline on April 6, 2026

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against BlackRock TCP Capital Corp. (“BlackRock TCP” or the “Company”) (NASDAQ: TCPC) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Geor...
-

Berkshire Hathaway Specialty Insurance Announces Employer Stop Loss Promotions

BOSTON--(BUSINESS WIRE)--BERKSHIRE HATHAWAY SPECIALTY INSURANCE ANNOUNCES EMPLOYER STOP LOSS PROMOTIONS...
-

Mobix Labs: $3.2M Order Received for Technology Used in TSA Airport Scanners

IRVINE, Calif.--(BUSINESS WIRE)--Mobix Labs: $3.2M Order Received for Technology Used in TSA Airport Scanners...
-

Quantum-Si Announces the Start of the Proteus™ Roadshow

BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces the Start of the Proteus™ Roadshow...
-

Marty Brennan Joins growth[period] as Chief Operating Officer

TYSONS CORNER, Va.--(BUSINESS WIRE)--growth[period], a strategic advisory firm serving clients at moments of growth, complexity, and transformation, announces addition of Marty Brennan....
-

SLNO Stock Alert: Halper Sadeh LLC is Investigating Whether Soleno Therapeutics, Inc. is Obtaining a Fair Price for its Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Soleno Therapeutics, Inc. (NASDAQ: SLNO) to Neurocrine Biosciences for $53.00 per share in cash.Halper Sadeh encourages Soleno shareholders to click here to learn more about their rights and options or contact Daniel Sadeh or Zachary Halper free of charge at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com.The investigation concerns whether Soleno and its board of directors vi...
-

Xoople Announces $130M Series B to Build Earth’s System of Record for the Agentic Era

MADRID--(BUSINESS WIRE)--Xoople, the data infrastructure company building a global system of record for physical change on Earth, announced it has closed a $130M Series B, bringing its total raised to $225M, from investors including Nazca Capital, MCH, CDTI (Government of Spain), Buenavista Equity Partners and Endeavor Catalyst. This capital makes Xoople the top funded company in the category, with satellites capable of producing the most precise, reliable, scientific-grade data sets that will...
-

ExtensisHR Appoints Alan Missen as Chief Information Officer

METROPARK, N.J.--(BUSINESS WIRE)--ExtensisHR announces the appointment of Alan Missen as Chief Information Officer (CIO)....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 02.04.2026 GRDU.LN IE000J80JTL1 28,375,002.00 USD 1,611,077,209.80 56.778  ...
-

RARE FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Ultragenyx Pharmaceutical (RARE) Investors of Securities Class Action Deadline on April 6, 2026

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ultragenyx Pharmaceutical Inc (“Ultragenyx” or the “Company”) (NASDAQ: RARE) and reminds investors of the April 6, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georg...